# TFAP2B

## Overview
TFAP2B is a gene that encodes the transcription factor AP-2β, a member of the AP-2 family of transcription factors. This protein plays a critical role in regulating gene expression by binding to specific DNA sequences, thereby influencing various biological processes. AP-2β is involved in the development and function of the nervous system, kidney, and mammary epithelium, among other tissues. It regulates the expression of genes associated with neurotransmitter systems and is essential for the differentiation of certain cell types, such as sympathetic neurons and chromaffin cells (AlSabri2022The; Raap2021Transcription). The protein's structure includes a highly conserved DNA binding domain and a helix-span-helix domain, which are crucial for its dimerization and DNA-binding capabilities (Liu2023Structural). Mutations in TFAP2B are linked to several clinical conditions, including Char syndrome and syndromic craniosynostosis, highlighting its significance in human health and disease (Timberlake2019Mutations; Satoda2000Mutations).

## Structure
The TFAP2B protein is characterized by a highly conserved DNA binding domain (DBD) followed by a helix-span-helix (HSH) domain. The DBD consists of two short antiparallel β-strands followed by three α-helices, while the HSH domain features a flat amphipathic α-helical fold. These domains are connected by a long loop containing a 3_10-helix (Liu2023Structural). The HSH domain is crucial for dimerization, forming homodimers through hydrophobic interactions, which are essential for the protein's stability and function (Liu2023Structural). The DBD forms a positively charged binding groove that interacts with double-stranded DNA, specifically recognizing the consensus sequence GCC(N3)GGC (Liu2023Structural).

TFAP2B can form both homodimers and heterodimers with other TFAP2 family members, which is necessary for its sequence-specific DNA binding (Liu2023Structural). The protein's structure is highly conserved among the TFAP2 family, sharing over 95% sequence similarity in the DBD and 75% in the HSH domain (Liu2023Structural). Post-translational modifications, such as phosphorylation, may regulate its activity, although specific modifications are not detailed in the provided context. Alternative splicing can result in different isoforms, potentially affecting its function and interactions (Eckert2005TheAP2familyoftranscriptionfactors).

## Function
The TFAP2B gene encodes the transcription factor AP-2β, which plays a significant role in various physiological processes in healthy human cells. AP-2β is involved in the regulation of monoaminergic neurotransmitter systems, enhancing the activity of neurotransmitters such as serotonin, dopamine, and adrenaline by controlling key genes in these systems (AlSabri2022The). It influences the expression of genes involved in the biosynthesis, degradation, and synaptic activity of these neurotransmitters, enhancing the transcription of genes for catecholamine-synthesizing enzymes while reducing the expression of catecholamine-degrading enzymes (AlSabri2022The).

AP-2β is crucial for the development and function of the nervous system, including the differentiation of sympathetic neurons and the maturation of chromaffin cells in the adrenal medulla (Raap2021Transcription). It also plays a role in the development of the kidney, particularly in the formation of distal convoluted tubules, and is essential for maintaining renal structure and function (Lamontagne2022Transcription). In the mammary epithelium, AP-2β is associated with differentiation and tissue homeostasis, co-expressing with GATA3 in a subpopulation of luminal cells (Raap2021Coexpression). These diverse roles highlight the importance of AP-2β in regulating key biological processes and maintaining cellular and organismal homeostasis.

## Clinical Significance
Mutations in the TFAP2B gene are associated with several clinical conditions, most notably Char syndrome, which is characterized by patent ductus arteriosus (PDA), facial dysmorphism, and hand anomalies. Char syndrome is caused by mutations that lead to a dominant-negative effect, disrupting the gene's ability to transactivate and affecting neural crest cell development, crucial for cardiovascular development (Satoda2000Mutations). Specific mutations such as A264D and R289C impair DNA binding and dimerization, contributing to the syndrome's pathogenesis (Satoda2000Mutations).

TFAP2B mutations have also been linked to syndromic craniosynostosis, a condition involving premature fusion of skull bones, and are associated with various congenital abnormalities, including clinodactyly and brachydactyly (Timberlake2019Mutations). Additionally, TFAP2B haploinsufficiency has been implicated in pediatric intestinal pseudo-obstruction (PIPO), affecting gastrointestinal function (Zada2022TFAP2B).

Alterations in TFAP2B expression are also associated with isolated dental anomalies and severe valvular aortic stenosis, with a noted autosomal-dominant inheritance pattern and incomplete penetrance (Tanasubsinn2017TFAP2B). These findings highlight the gene's role in a spectrum of disorders, demonstrating its pleiotropic effects and variable expressivity.

## Interactions
The TFAP2B gene encodes the transcription factor AP-2β, which participates in various protein-protein and protein-DNA interactions. AP-2β forms homodimers or heterodimers with other members of the AP-2 family, such as TFAP2A and TFAP2C, through its helix-span-helix (HSH) domain. This dimerization is crucial for its DNA-binding ability, allowing it to regulate gene expression by binding to specific DNA sequences, particularly the consensus sequence GCC(N3)GGC (Liu2023Structural).

AP-2β interacts with coactivators and corepressors that modulate its transcriptional activity. Coactivators such as CITED2, CITED4, and YEATS4 enhance its transcriptional activation, while proteins like KCTD1 and KCTD15 inhibit its activity by binding to its transactivation domain (AlSabri2022The). The transcriptional activity of AP-2β is also influenced by post-translational modifications, such as sumoylation, which can either decrease or enhance its activity depending on the interacting proteins (AlSabri2022The).

In addition, AP-2β's interaction with p300 and CBP, in the presence of CITED2, enhances its transcriptional activity. This interaction is crucial for the full transcriptional activation of TFAP2 isoforms, including TFAP2B (Bragança2003Physical). These interactions highlight the complex regulatory network in which AP-2β is involved, influencing various biological processes and disease states.


## References


[1. (Lamontagne2022Transcription) Joseph O. Lamontagne, Hui Zhang, Alia M. Zeid, Karin Strittmatter, Alicia D. Rocha, Trevor Williams, Sheryl Zhang, and Alexander G. Marneros. Transcription factors ap-2α and ap-2β regulate distinct segments of the distal nephron in the mammalian kidney. Nature Communications, April 2022. URL: http://dx.doi.org/10.1038/s41467-022-29644-3, doi:10.1038/s41467-022-29644-3. This article has 9 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-29644-3)

[2. (Tanasubsinn2017TFAP2B) Natchaya Tanasubsinn, Rekwan Sittiwangkul, Yupada Pongprot, Katsushige Kawasaki, Atsushi Ohazama, Thanapat Sastraruji, Massupa Kaewgahya, and Piranit Nik Kantaputra. Tfap2b mutation and dental anomalies. Journal of Human Genetics, 62(8):769–775, April 2017. URL: http://dx.doi.org/10.1038/jhg.2017.37, doi:10.1038/jhg.2017.37. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/jhg.2017.37)

[3. (Zada2022TFAP2B) Almira Zada, Laura E. Kuil, Bianca M. de Graaf, Naomi Kakiailatu, Jonathan D. Windster, Alice S. Brooks, Marjon van Slegtenhorst, Barbara de Koning, René M. H. Wijnen, Veerle Melotte, Robert M. W. Hofstra, Erwin Brosens, and Maria M. Alves. Tfap2b haploinsufficiency impacts gastrointestinal function and leads to pediatric intestinal pseudo-obstruction. Frontiers in Cell and Developmental Biology, July 2022. URL: http://dx.doi.org/10.3389/fcell.2022.901824, doi:10.3389/fcell.2022.901824. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2022.901824)

[4. (Raap2021Coexpression) M. Raap, L. Gierendt, C. Werlein, E. Kuehnle, H. H. Kreipe, and M. Christgen. Co-expression of transcription factor ap-2beta (tfap2b) and gata3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for ck8/18. Journal of Molecular Histology, 52(6):1257–1264, June 2021. URL: http://dx.doi.org/10.1007/s10735-021-09980-2, doi:10.1007/s10735-021-09980-2. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10735-021-09980-2)

[5. (Eckert2005TheAP2familyoftranscriptionfactors) Dawid Eckert, Sandra Buhl, Susanne Weber, Richard Jäger, and Hubert Schorle. The ap-2 family of transcription factors. Genome Biology, 6(13):246, 2005. URL: http://dx.doi.org/10.1186/gb-2005-6-13-246, doi:10.1186/gb-2005-6-13-246. This article has 507 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2005-6-13-246)

[6. (Satoda2000Mutations) Masahiko Satoda, Feng Zhao, George A. Diaz, John Burn, Judith Goodship, H. Rosemarie Davidson, Mary Ella M. Pierpont, and Bruce D. Gelb. Mutations in tfap2b cause char syndrome, a familial form of patent ductus arteriosus. Nature Genetics, 25(1):42–46, May 2000. URL: http://dx.doi.org/10.1038/75578, doi:10.1038/75578. This article has 216 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/75578)

[7. (Timberlake2019Mutations) Andrew T. Timberlake, Sheng Chih Jin, Carol Nelson-Williams, Robin Wu, Charuta G. Furey, Barira Islam, Shozeb Haider, Erin Loring, Amy Galm, Derek M. Steinbacher, Dawid Larysz, David A. Staffenberg, Roberto L. Flores, Eduardo D. Rodriguez, Titus J. Boggon, John A. Persing, Richard P. Lifton, Richard P. Lifton, Murat Gunel, Shrikant Mane, Kaya Bilguvar, Mark Gerstein, Erin Loring, Carol Nelson-Williams, Francesc Lopez, and Jim Knight. Mutations in tfap2b and previously unimplicated genes of the bmp, wnt, and hedgehog pathways in syndromic craniosynostosis. Proceedings of the National Academy of Sciences, 116(30):15116–15121, July 2019. URL: http://dx.doi.org/10.1073/pnas.1902041116, doi:10.1073/pnas.1902041116. This article has 22 citations.](https://doi.org/10.1073/pnas.1902041116)

[8. (Bragança2003Physical) José Bragança, Jyrki J. Eloranta, Simon D. Bamforth, J. Claire Ibbitt, Helen C. Hurst, and Shoumo Bhattacharya. Physical and functional interactions among ap-2 transcription factors, p300/creb-binding protein, and cited2. Journal of Biological Chemistry, 278(18):16021–16029, May 2003. URL: http://dx.doi.org/10.1074/JBC.M208144200, doi:10.1074/jbc.m208144200. This article has 197 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M208144200)

[9. (AlSabri2022The) Mohamed H. Al-Sabri, Maryam Nikpour, Laura E. Clemensson, Misty M. Attwood, Michael J. Williams, Mathias Rask-Anderson, Jessica Mwinyi, and Helgi B. Schiöth. The regulatory role of ap-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential. Cell &amp; Bioscience, September 2022. URL: http://dx.doi.org/10.1186/s13578-022-00891-7, doi:10.1186/s13578-022-00891-7. This article has 3 citations.](https://doi.org/10.1186/s13578-022-00891-7)

[10. (Raap2021Transcription) Mieke Raap, Lisa Gierendt, Hans H. Kreipe, and Matthias Christgen. Transcription factor <scp>ap</scp>‐2beta in development, differentiation and tumorigenesis. International Journal of Cancer, 149(6):1221–1227, March 2021. URL: http://dx.doi.org/10.1002/ijc.33558, doi:10.1002/ijc.33558. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.33558)

[11. (Liu2023Structural) Ke Liu, Yuqing Xiao, Linyao Gan, Weifang Li, Jin Zhang, and Jinrong Min. Structural basis for specific dna sequence motif recognition by the tfap2 transcription factors. Nucleic Acids Research, 51(15):8270–8282, July 2023. URL: http://dx.doi.org/10.1093/nar/gkad583, doi:10.1093/nar/gkad583. This article has 5 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkad583)